ReviewTherapeutic advances in endocrinology and metabolism2023

Fatty liver disease in children (MAFLD/PeFLD Type 2): unique classification considerations and challenges.

Robert Hegarty et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.